Mepiroxol

Mepiroxol

SCHEMBL904581

[O-][n+]1cccc(CO)c1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL317674 0.79
SCHEMBL1089058 0.77
SCHEMBL11448986 0.77
SCHEMBL1026110 0.77
SCHEMBL14844558 0.77
SCHEMBL1944623 0.77
SCHEMBL317676 0.77
SCHEMBL8897237 0.77 GPR84 (0.42)
SCHEMBL10390039 0.76 GPR84 (0.62)
Hydrochloric Acid SCHEMBL2123585 0.76 GPR84 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9016221-B2 Surface topographies for non-toxic bioadhesion control UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-04-28 US claimed
US-20100226943-A1 SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL UNIVERSITY OF FLORIDA (US) 2010-09-09 US claimed
EP-1954244-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY Scidose, Llc (US) 2008-08-13 EP claimed
WO-2007061529-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY SCIDOSE LLC. (US) 2007-05-31 WO claimed
US-20070116729-A1 Lyophilization process and products obtained thereby SCIDOSE LLC 2007-05-24 US claimed
US-20260027215-A1 COMPOSITIONS FOR TRANSPORT OF THERAPEUTIC CARGOS USING BINDERS TARGETING CA-IV RECEPTIVE BIO INC (US) 2026-01-29 US disclosed
WO-2025129358-A1 STABLE FILM FORMULATIONS FOR HIGH LOADING OF LOW MELTING POINT ACTIVES INTELGENX CORP. (CA) 2025-06-26 WO disclosed
US-20250140406-A1 CLASSIFYING TUMORS AND PREDICTING RESPONSIVENESS INSIGHT MOLECULAR DIAGNOSTICS INC. 2025-05-01 US disclosed
US-20250049911-A1 IMPLANTABLE SCAFFOLDS FOR IMMUNOTHERAPEUTIC AND OTHER USES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-02-13 US disclosed
WO-2023114418-A9 IMPLANTABLE SCAFFOLDS FOR IMMUNOTHERAPEUTIC AND OTHER USES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-11-14 WO disclosed
EP-4448004-A1 IMPLANTABLE SCAFFOLDS FOR IMMUNOTHERAPEUTIC AND OTHER USES The Regents of University of California (US) 2024-10-23 EP disclosed
US-11759445-B2 Use of Rivastigmine in preparation of anti-radiation medicament SOOCHOW UNIVERSITY (CN) 2023-09-19 US disclosed
US-4316043-A ANTIEDEMIC AGENTS MERCK & CO., INC. (US) 1982-02-16 US disclosed
EP-0041587-A1 Catalyst compositions, production thereof, and use in production of oxygenated organic compounds THE STANDARD OIL COMPANY (US) 1981-12-16 EP disclosed
US-4293391-A Cadmium plating baths and methods for electrodepositing bright cadmium deposits ROHCO, INC. (US) 1981-10-06 US disclosed
US-4270989-A AN AQUEOUS SOLUTION OF A IONIZABLE CADMIUM COMPOUND, A FREE ACID, AND AN ALKYLENE OXIDE ADDUCT OR A POLYOXYALKYLENE GLYCOL HAVING A PHOSPHATE, CARBOXYLATE, OR ARYL SULFATE GROUP ROHCO, INC. (US) 1981-06-02 US disclosed
EP-0027948-A1 Tetrahydro-fluorene compounds, processes for their preparation and pharmaceutical compositions thereof MERCK & CO. INC. (US) 1981-05-06 EP disclosed
US-4212976-A ANTIARTHRITIC AGENTS MERCK & CO., INC. (US) 1980-07-15 US disclosed
US-4057637-A RHEUMATOID ARTHRITIS MERCK & CO., INC. (US) 1977-11-08 US disclosed
US-3971797-A ANTIARTHRITIC MERCK & CO., INC. (US) 1976-07-27 US disclosed